158 related articles for article (PubMed ID: 20585202)
1. Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance.
Prasad R; Johnston LB; Savage MO; Martin L; Perry LA; Storr HL
J Endocrinol Invest; 2011 Apr; 34(4):296-9. PubMed ID: 20585202
[TBL] [Abstract][Full Text] [Related]
2. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
3. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
4. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
5. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
7. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
[TBL] [Abstract][Full Text] [Related]
8. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
9. Two pediatric patients with Von Hippel-Lindau disease type 2b: from patient to screening, from screening to patient.
Gonc N; Engiz O; Neumann HP; Demirbilek H; Ozon A; Alikasifoglu A; Kandemir N
J Pediatr Endocrinol Metab; 2011; 24(1-2):109-12. PubMed ID: 21528828
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
11. [Von Hippel-Lindau disease: family study].
González Escobar AB; Morillo Sánchez MJ; García-Campos JM
Arch Soc Esp Oftalmol; 2012 Nov; 87(11):368-72. PubMed ID: 23058196
[TBL] [Abstract][Full Text] [Related]
12. Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease.
Piermarocchi S; Lo Giudice G; Pilotto E; Bertoja E; Scaroni C; Martella M; Opocher G; Murgia A
Graefes Arch Clin Exp Ophthalmol; 2000 Jul; 238(7):615-20. PubMed ID: 10955664
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred.
Atuk NO; Stolle C; Owen JA; Carpenter JT; Vance ML
J Clin Endocrinol Metab; 1998 Jan; 83(1):117-20. PubMed ID: 9435426
[TBL] [Abstract][Full Text] [Related]
14. [Mitral regurgitation of unknown etiology in a 20-year-old patient].
Caro J; Inmaculada Navarro-Hidalgo M; Bonanad C; Real JT; Ascaso JF
Endocrinol Nutr; 2012 May; 59(5):333-5. PubMed ID: 22244657
[No Abstract] [Full Text] [Related]
15. A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C.
Schreinemakers JM; Zonnenberg BA; Höppener JW; Hes FJ; Rinkes IH; Lips CJ
World J Surg Oncol; 2007 Oct; 5():112. PubMed ID: 17922902
[TBL] [Abstract][Full Text] [Related]
16. A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.
Arao T; Okada Y; Tanikawa T; Inatomi H; Shuin T; Fujihira T; Yamashita H; Tanaka Y
Endocr J; 2002 Apr; 49(2):181-8. PubMed ID: 12081237
[TBL] [Abstract][Full Text] [Related]
17. Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.
Vérot PL; Rabattu PY; Chabre O; Gayot A; Sartelet H; Faguet R; Robert Y; Piolat C
Arch Pediatr; 2020 Nov; 27(8):497-501. PubMed ID: 33067065
[TBL] [Abstract][Full Text] [Related]
18. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.
Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W
Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528
[TBL] [Abstract][Full Text] [Related]
19. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
[TBL] [Abstract][Full Text] [Related]
20. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.
Shuin T; Yamasaki I; Tamura K; Okuda H; Furihata M; Ashida S
Jpn J Clin Oncol; 2006 Jun; 36(6):337-43. PubMed ID: 16818478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
